- HealthTech
- Thursday, 21 Dec 2023
CT Scanner Market is expected to reach US$ 9,596.26 million by 2030
According to our new research study on “CT Scanner Market Size and Forecast to 2030 – Global and Regional Analysis – by Type, Architecture, Technology, Application, and End User,” the CT Scanner market is expected to grow US$ 6,325.00 million in 2022 to US$ 9,596.26 million by 2030; the market is estimated to register a CAGR of 5.35% from 2022 to 2030. Key factors driving the market include the increase in the prevalence of chronic diseases, growing demand for early diagnosis, and the development of healthcare infrastructure. Further, technological advancements in CT scanners are anticipated to introduce new trends in the market during 2022–2030.
However, the high cost associated with the maintenance and installation of the scanners and limited reimbursement policies hampers the market growth. Further, strategic developments through company acquisitions and partnerships create opportunities in the CT Scanner market.
To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPHE100001287
A CT scanner is a medical imaging technology device that uses X-rays from multiple angles to generate detailed images of the body's bones, blood vessels, and soft tissues. These images provide more detail than traditional X-rays. In addition, CT scanners are widely used to examine people who may have internal injuries due to car accidents or other types of traumas. This scan can visualize almost all body parts and help diagnose injuries or diseases. Additionally, it is used to plan medical, surgical, or radiation treatment for the affected areas during disease diagnosis.
The CT scanner market, based on geography, is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
The CT scanner market is segmented based on type, architecture, technology, application, and end user. The CT scanner market is segmented based on type into stationary and portable CT scanners. The stationary CT scanners segment held a larger market share in 2022 and is anticipated to register a higher CAGR during 2022–2030.
The CT scanner market, based on architecture, is bifurcated into C-arm CT Scanners and O-arm CT Scanners. The C-arm CT Scanners segment dominated the market in 2020.
The segment of C-arms is expected to experience substantial growth due to the rising use of C-arms in interventional surgical procedures, owing to their open architecture and easy access to patients. The focus of major players on obtaining approvals from regulatory bodies to introduce new products to the market is expected to favor the segment between 2023 and 2030. For instance, in March 2021, GE Healthcare’s OEC 3D, a new surgical imaging system capable of 3D and 2D imaging, received 510(k) clearance from the US Food and Drug Administration (FDA). The system uses interoperative 3D imaging by providing precise volumetric images for spine and orthopedic procedures. OEC 3D combines the benefits of 2D imaging with greater efficiency to increase access and usability to 3D.
CT Scanner Market: Competitive Landscape and Key Developments
GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., TOSHIBA IT and CONTROL SYSTEMS CORPORATION, HTSI Healthcare Solutions, Shimadzu Corporation, SAMSUNGHEALTHCARE.COM, Neusoft Corporation, Medtronic, and Shenzhen Anke High-Tech Co., Ltd are the major players operating in the CT scanner market. These leading players adopt strategies such as launching new products, expanding and diversifying market presence, expanding new customer base, and tapping prevailing business opportunities.
A few of the inorganic strategies opted for by players in the CT scanner market are mentioned below:
- In November 2022, FUJIFILM launched SCENARIA View Focus Edition, a premium CT scanner in the US. It features Cardio StillShot, an advanced Cardiac Motion Correction feature, which enables 6x higher temporal resolution than conventional image reconstruction methods. The device is suitable for routine and advanced clinical applications and was introduced at RSNA 2022.
- In April 2022, Wipro GE Healthcare launched its advanced Revolution Aspire CT scanner. The CT system is designed and manufactured entirely in India at the Wipro GE Medical Devices Manufacturing plant. It has higher imaging intelligence for more accurate clinical diagnosis.
- In November 2021, Siemens Healthineers launched Naeotom Alpha, the first photon-counting CT scanner cleared for clinical use in the US and Europe. Photon-counting technology enables drastic improvements, including increased resolution and reduced radiation dose for ultra-high-resolution scans compared to conventional CT detectors.
Contact Us
Contact Us: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
North America Dental Surgery Instruments Market is Rising during 2020-2027 with Top Key Players Like 3M, Danaher, Hu-Friedy Mfg
Sep 18, 2020
Patient-controlled Analgesic Infusion Pumps Market: Supply-Demand, Industry Research and End User Analysis, Outlook 2027
Feb 17, 2021
Surgical Scalpel Market Forecast 2027: Top Companies, Revenue and Growth Factors Details for Business Development
Aug 20, 2020
Why Transplantation Market Trending in 2020? Know COVID-19 Impact on Growth and Forecast Research till 2027
Dec 01, 2020
RTLS for Healthcare Market is expected to reach US$ 9.36 billion by 2030
Feb 14, 2024
Agile-Based Medical Devices Design Market Scenario, Comprehensive Analysis, Professional Survey, Top Companies and Future Growth Prospect by Forecast to 2027
Dec 09, 2020
Global Constipation Treatment Market (2020) to Witness Huge Growth by 2027 | Mallinckrodt Plc, Abbott, Cosmo Pharma, Sanofi, Albireo Pharma, Inc, AstraZeneca
Apr 16, 2021